Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Durect Corp (DRRX)

2.06 -0.01 (-0.48%)

04-24 16:00

Open:

2.05

Pre. Close:

2.07

High:

2.15

Low:

2.04

Volume:

429,432

Market Cap:

316M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.164 - 2.185

2.185 - 2.197

Low:

1.997 - 2.023

2.023 - 2.039

Close:

2.03 - 2.073

2.073 - 2.099

Technical analysis  (as of: 2018-04-24 4:24:02 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 2.60     One year: 2.98

Support:

Support1: 1.71    Support2: 1.42

Resistance:

Resistance1: 2.23    Resistance2: 2.55

Pivot:

2.35

Moving Averages:

MA(5): 2.17     MA(20): 2.30

MA(100): 1.47     MA(250): 1.45

MACD:

MACD(12,26): 0.07     Signal(12,26,9): 0.15

%K %D:

%K(14,3): 24.19     %D(3): 34.13

RSI:

RSI(14): 42.58

52-Week:

High: 2.55  Low: 0.74  Change(%): 139.5

Average Vol(K):

3-Month: 95956  10-Days 80677

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
DRRX has closed above bottom band by 6.2%. Bollinger Bands are 56.5% wider than normal. The large width of the bands suggest high volatility as compared to DRRX's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

2018-04-24T16:30:00-04:00
DURECT Corporation Invites You to Join its First Quarter 2018 Earnings Conference Call

2018-04-19T11:25:01-04:00
U.S. opioid prescriptions down 12% last year, largest drop in 25 years

2018-04-17T15:35:03-04:00
DEA aiming to collar production of opioids

2018-04-17T12:03:04-04:00
Sen. Sanders introduces bill to fine opioid makers for marketing practices

2018-04-06T13:12:58-04:00
DURECT (DRRX) Alcoholic Hepatitis Phase 2a Study - Slideshow

2018-03-29T08:00:00-04:00
DURECT Corporation to Host Key Opinion Leader Call on Alcoholic Hepatitis

2018-03-23T07:58:08-04:00
DURECT Corporation: Upcoming Milestones And DUR-928 Progress

2018-03-20T08:00:00-04:00
DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

153.34

Shares Float (M)

147.99

% Held by Insiders

3.50

% Held by Institutions

42.70

Shares Short (K)

1556

Shares Short Prior Month (K)

1660

Stock Financials

EPS

-0.040

EPS Est. Current Year

-0.240

EPS Est. Next Year

-0.170

EPS Est. Next Quarter

-0.050

Forward EPS

-0.220

Book Value (p.s.)

15.270

PEG Ratio

-0.59

Profit Margin

9.91

Operating Margin

-40.19

Return on Assets (ttm)

-7.9

Return on Equity (ttm)

-24.8

Qtrly Rev. Growth

455.5

Gross Profit (p.s.)

0.157

Sales Per Share

EBITDA (p.s.)

-0.064

Qtrly Earnings Growth

Operating Cash Flow (M)

-1.34

Levered Free Cash Flow (M)

-8.72

atoplab.com

Valuation

P/E

-51.50

P/E Growth Ratio

P/BV

0.13

P/S

1263521664.00

P/CF

-235.73

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.